company was at Baht 5,402 million, increased by Baht 3,273 million or 154% from Q1/2019, and increased Baht 3,771 million or 231% from Q2/2018. this is mainly due to the immediate recognition of GLOW’s

at 13.00 p.m., took place at the Meeting Room No.1, 14th Floor, TP&T Building, number 1, Vibhavadi Rangsit 19 Alley, Chompol Subdistrict, Chatuchak District, Bangkok, the material matters resolved in

, which is the maximum transaction value based on the Consolidated Financial Statement of the Company as at 30 June 2017, which is higher than 15 percent but less than 50 percent. Accordingly, the Company

decreased at similar rate to the decrease in total revenue. In addition, in 2022, the Company recorded the impairment loss on financial assets by 96. 8 MB and the Fair value loss on FVTPL equity instrument by

parties and contains at least the particulars and substances as specified by the SEC Office. 2A contract or an agreement in Paragraph 1 shall not have any statement that are in the manner of denying or

contains at least the particulars and substances as specified by the SEC Office. 2 A contract or an agreement in Paragraph 1 shall not have any statement that are in the manner of denying or limiting

contains at least the particulars and substances as specified by the SEC Office. 2A contract or an agreement in Paragraph 1 shall not have any statement that are in the manner of denying or limiting

:- Derivative financial instruments are used to manage exposure to foreign exchange and interest rate risks, which are recognized initially at fair value. Subsequent to initial recognition, they are remeasured at

: General patients’ revenue for the quarter ended 31 March 2020 was 1,385.99 million baht, an increase of 39.37 million baht or 2.92 percent which grew at lower rate compared to that of last year, mainly due

13 December 2019. On 31 December 2019, the company has hold a total of 1,460,360,024 shares of GLOW or 99.83% of the total issued shares of GLOW. For 2019, the net profit of the company was at Baht